Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T with OPV in Healthy Children
NCT00192426Phase 3Completed
- Sponsor
- MedImmune
- Start
- Sep 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, single-blind trial of live attenuated influenza vaccine in influenza (3 arms), sponsored by MedImmune. Primary endpoint: Proportion of subjects achieving a post-vaccination serum antibody response. Started Sep 2001; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192426.